Xu Cheng Selected Research

12-Hydroxy-5,8,10,14-eicosatetraenoic Acid

10/2021	Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species.
1/2018	An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Cheng Research Topics

Disease

61	Neoplasms (Cancer) 11/2022 - 09/2011
11	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2011
9	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2019
8	Breast Neoplasms (Breast Cancer) 08/2022 - 07/2012
8	COVID-19 01/2021 - 01/2020
6	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
6	Inflammation (Inflammations) 01/2022 - 07/2015
5	Infections 08/2022 - 10/2017
5	Reperfusion Injury 01/2022 - 11/2020
5	Myopia 01/2021 - 04/2016
4	Pain (Aches) 01/2022 - 09/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
4	Liver Diseases (Liver Disease) 12/2021 - 01/2018
4	Cleft Lip (Harelip) 07/2019 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 06/2014
3	Adenocarcinoma of Lung 11/2022 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 11/2020
3	Fibrosis (Cirrhosis) 01/2022 - 07/2015
3	Carcinogenesis 01/2022 - 11/2003
3	Ureteral Obstruction 01/2022 - 12/2004
3	Carcinoma (Carcinomatosis) 01/2022 - 04/2016
3	Ischemia 10/2021 - 01/2018
3	Postoperative Cognitive Complications 01/2021 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 11/2012
3	Congenital Abnormalities (Deformity) 11/2018 - 01/2018
3	Refractive Errors (Refractive Error) 01/2004 - 12/2002
2	Body Weight (Weight, Body) 03/2022 - 02/2016
2	Obesity 01/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2013
2	Lymphatic Metastasis 01/2022 - 09/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2018
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2020
2	Heart Diseases (Heart Disease) 01/2021 - 10/2020
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2018
2	Osteolysis 12/2020 - 01/2020
2	Hypoxia (Hypoxemia) 01/2020 - 01/2018
2	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2020
2	Stroke (Strokes) 09/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

19	Pharmaceutical PreparationsIBA 01/2022 - 10/2015
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
9	EstersIBA 11/2021 - 01/2017
9	NanogelsIBA 11/2021 - 09/2017
7	AcidsIBA 11/2021 - 09/2016
7	MicellesIBA 11/2020 - 10/2015
5	LigandsIBA 11/2022 - 01/2017
5	Long Noncoding RNAIBA 01/2022 - 01/2018
4	LipidsIBA 01/2022 - 10/2013
4	PolymersIBA 09/2021 - 10/2015
4	Messenger RNA (mRNA)IBA 09/2021 - 11/2003
4	Drug CarriersIBA 08/2021 - 01/2017
4	Biological ProductsIBA 01/2020 - 01/2004
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2018
3	Competitive Endogenous RNAIBA 01/2022 - 01/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 08/2019
3	Therapeutic UsesIBA 11/2021 - 09/2019
3	tocophersolanIBA 11/2020 - 10/2018
3	EnzymesIBA 01/2020 - 11/2003
3	Soybean Proteins (Soy Protein)IBA 09/2019 - 01/2017
3	ElementsIBA 11/2018 - 01/2018
2	thiocyanateIBA 08/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
2	Poly I-CIBA 01/2022 - 11/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2016
2	Circular RNAIBA 01/2022 - 01/2020
2	MetalsIBA 01/2022 - 09/2021
2	benzeneboronic acidIBA 11/2021 - 09/2016
2	monomethoxypolyethylene glycol (MPEG)IBA 11/2021 - 10/2015
2	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 10/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 01/2021
2	PlasticsIBA 01/2021 - 11/2018
2	AndrogensIBA 01/2021 - 07/2020
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 12/2004
2	Atropine FDA LinkGeneric 01/2021 - 07/2019
2	Interferon Type IIBA 01/2021 - 01/2018
2	CytokinesIBA 11/2020 - 01/2015
2	ProdrugsIBA 11/2020 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 10/2020 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 06/2020 - 01/2020
2	Indomethacin (Indometacin)FDA LinkGeneric 06/2020 - 08/2019
2	Dextrans (Dextran)FDA Link 06/2020 - 10/2018
2	Poloxamer (Poloxamer 407)IBA 04/2020 - 04/2020
2	ImmunosorbentsIBA 01/2020 - 11/2003
2	Cisplatin (Platino)FDA LinkGeneric 04/2019 - 01/2016
2	lactobionic acid (lactobionate)IBA 07/2018 - 09/2017
2	carboxymethyl-chitosanIBA 09/2017 - 04/2017
2	Ribonucleases (Ribonuclease)IBA 09/2016 - 01/2015

Therapy/Procedure

27	Therapeutics 11/2022 - 11/2012
11	Drug Therapy (Chemotherapy) 01/2022 - 06/2014
5	Radiotherapy 01/2022 - 03/2011
4	Lenses 01/2021 - 12/2002
4	Aftercare (After-Treatment) 12/2020 - 10/2013
3	Prostatectomy (Retropubic Prostatectomy) 08/2022 - 06/2020
3	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 05/2020 - 04/2016
3	Nephrectomy 08/2017 - 01/2015
2	Adjuvant Chemotherapy 01/2022 - 07/2021
2	Immunotherapy 01/2022 - 01/2021
2	Catheters 06/2020 - 01/2020
2	Sutures (Suture) 01/2020 - 07/2019